$NWBO Up to date company activities and other impo
Post# of 94277
Posted On: 06/04/2014 7:12:49 PM
$NWBO Up to date company activities and other important information about $NWBO
$NWBO
DD Notes ~ http://www.ddnotesmaker.com/NWBO
##### recent news/filings ~ source: finance.yahoo.com
Wed, 04 Jun 2014 18:18:00 GMT ~ SummerStreet Research Partners Reiterates Buy Rating of Northwest Biotherapeutics, Inc.
- New York, NY / June 4, 2014 / Market Exclusive announces that SummerStreet Research Partners has reiterated a BUY rating and year end 2014 price target or $15.10 on Northwest Biotherapeutics, Inc. (NASDAQ: ...
read full: http://finance.yahoo.com/news/marketexclusive...00078.html
*********************************************************
Wed, 04 Jun 2014 16:25:14 GMT ~ The Case Of Northwest Biotherapeutics' Missing DMC Recommendation
read full: http://seekingalpha.com/article/2252553-the-c...urce=yahoo
*********************************************************
Wed, 04 Jun 2014 15:23:00 GMT ~ NW BIO TO PRESENT AT JEFFERIES 2014 GLOBAL HEALTHCARE CONFERENCE
- BETHESDA, Md., June 4, 2014 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (NWBO) ("NW Bio"
, a biotechnology company developing DCVax® personalized immune therapies for cancer, announced today that Linda F. Powers, CEO, will present at the Jefferies 2014 Global Healthcare Conference, which is being held in New York. NW Bio's presentation will take place on Wednesday, June 4, at 2:00 p.m. EDT in Ballroom 5 at the Grand Hyatt in New York City. There will be a live webcast of the presentation available at http://wsw.com/webcast/jeff82/nwbo. During her presentation, Ms. Powers will provide an overview of the Company's cancer vaccine platform technology, product pipeline and clinical programs with DCVax-L and DCVax-Direct. Northwest Biotherapeutics is a biotechnology company focused on developing immunotherapy products to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies, and on a cost-effective basis, in both the United States and Europe. The Company has a broad platform technology for DCVax dendritic cell-based vaccines. The Company's lead program is a 312-patient Phase III trial in newly diagnosed Glioblastoma multiforme (GBM). GBM is the most aggressive and lethal form of brain cancer. The Company is also under way with a 60-patient Phase I/II trial with DCVax-Direct for all inoperable solid tumors cancers, with a primary efficacy endpoint of tumor regression. The Company also previously received clearance from the FDA for a 612-patient Phase III trial in prostate cancer. The Company also conducted a Phase I/II trial with DCVax for metastatic ovarian cancer together with the University of Pennsylvania.
read full: http://finance.yahoo.com/news/nw-bio-present-...00882.html
*********************************************************
Mon, 02 Jun 2014 19:05:53 GMT ~ Northwest Biotherapeutics: Academic Results Create Positive Risk/Reward
read full: http://seekingalpha.com/article/2249183-north...urce=yahoo
*********************************************************
Mon, 02 Jun 2014 15:23:00 GMT ~ If You Build It, They Will Chuckle: Northwest Bio's Super-Sized ASCO '14 Booth
read full: http://www.thestreet.com/story/12729851/1/if-..._ven=YAHOO
*********************************************************
##### chart ~ source: stockcharts.com
stockcharts.com/c-sc/sc?s=NWBO&p=D&b=5&g=0&id=p95448242713
##### chart ~ source: eoddata.com
http://chart.eoddata.com/?e=OTCBB&s=NWBO&...D&b=BB
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/NWBO/company-info
Ticker: $NWBO
OTC Market Place: Not Available
CIK code: 0001072379
Company name: Northwest Biotherapeutics, Inc.
Company website: http://www.nwbio.com
Incorporated In: DE, USA
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/NWBO/filings
Latest financials: http://www.otcmarkets.com/stock/NWBO/financials
Latest news: http://www.otcmarkets.com/stock/NWBO/news - http://finance.yahoo.com/q/h?s=NWBO+Headlines
Major holdings: http://data.cnbc.com/quotes/NWBO/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=NWBO+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/NWBO.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=NWBO
RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search
DTCC: http://search2.dtcc.com/?q=Northwest+Biothera...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...ics%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.nwbio.com
Alexa: http://www.alexa.com/siteinfo/http://www.nwbio.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.nwbio.com
Short Sales: http://www.otcmarkets.com/stock/NWBO/short-sales
Insider Disclosure: http://www.otcmarkets.com/stock/NWBO/insider-transactions
Research Reports: http://www.otcmarkets.com/stock/NWBO/research
Historical Prices: http://finance.yahoo.com/q/hp?s=NWBO+Historical+Prices
Basic Tech. Analysis: http://finance.yahoo.com/q/ta?s=NWBO+Basic+Tech.+Analysis
Company Profile: http://finance.yahoo.com/q/pr?s=NWBO+Profile
Key Statistics: http://finance.yahoo.com/q/ks?s=NWBO+Key+Statistics
Industry: http://finance.yahoo.com/q/in?s=NWBO+Industry
Insider Roster: http://finance.yahoo.com/q/ir?s=NWBO+Insider+Roster
Income Statement: http://finance.yahoo.com/q/is?s=NWBO
Balance Sheet: http://finance.yahoo.com/q/bs?s=NWBO
Cash Flow: http://finance.yahoo.com/q/cf?s=NWBO+Cash+Flow&annual
Market Watch: http://www.marketwatch.com/investing/stock/NWBO
Bloomberg: http://www.bloomberg.com/quote/NWBO:US
Morningstar: http://quotes.morningstar.com/stock/s?t=NWBO
Bussinessweek: http://investing.businessweek.com/research/st...icker=NWBO
Barchart: http://www.barchart.com/quotes/stocks/NWBO
OTC Short Report: http://otcshortreport.com/index.php?index=NWBO
Investopedia: http://www.investopedia.com/markets/stocks/NWBO/?wa=0
http://www.pennystocktweets.com/stocks/profile/NWBO
##### last known share structure ~ source: otcmarkets.com
Market Value: $337,455,320 a/o Jun 03, 2014
Shares Outstanding: 57,195,817 a/o May 14, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
##### business description ~ source: otcmarkets.com
Northwest Biotherapeutics, Inc. is a development stage biotechnology company focused on discovering, developing and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer. The Company operates in the United States and is incorporated in Delaware, USA.
DD Notes ~ http://www.ddnotesmaker.com/NWBO
$NWBO
DD Notes ~ http://www.ddnotesmaker.com/NWBO
##### recent news/filings ~ source: finance.yahoo.com
Wed, 04 Jun 2014 18:18:00 GMT ~ SummerStreet Research Partners Reiterates Buy Rating of Northwest Biotherapeutics, Inc.
- New York, NY / June 4, 2014 / Market Exclusive announces that SummerStreet Research Partners has reiterated a BUY rating and year end 2014 price target or $15.10 on Northwest Biotherapeutics, Inc. (NASDAQ: ...
read full: http://finance.yahoo.com/news/marketexclusive...00078.html
*********************************************************
Wed, 04 Jun 2014 16:25:14 GMT ~ The Case Of Northwest Biotherapeutics' Missing DMC Recommendation
read full: http://seekingalpha.com/article/2252553-the-c...urce=yahoo
*********************************************************
Wed, 04 Jun 2014 15:23:00 GMT ~ NW BIO TO PRESENT AT JEFFERIES 2014 GLOBAL HEALTHCARE CONFERENCE
- BETHESDA, Md., June 4, 2014 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (NWBO) ("NW Bio"
, a biotechnology company developing DCVax® personalized immune therapies for cancer, announced today that Linda F. Powers, CEO, will present at the Jefferies 2014 Global Healthcare Conference, which is being held in New York. NW Bio's presentation will take place on Wednesday, June 4, at 2:00 p.m. EDT in Ballroom 5 at the Grand Hyatt in New York City. There will be a live webcast of the presentation available at http://wsw.com/webcast/jeff82/nwbo. During her presentation, Ms. Powers will provide an overview of the Company's cancer vaccine platform technology, product pipeline and clinical programs with DCVax-L and DCVax-Direct. Northwest Biotherapeutics is a biotechnology company focused on developing immunotherapy products to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies, and on a cost-effective basis, in both the United States and Europe. The Company has a broad platform technology for DCVax dendritic cell-based vaccines. The Company's lead program is a 312-patient Phase III trial in newly diagnosed Glioblastoma multiforme (GBM). GBM is the most aggressive and lethal form of brain cancer. The Company is also under way with a 60-patient Phase I/II trial with DCVax-Direct for all inoperable solid tumors cancers, with a primary efficacy endpoint of tumor regression. The Company also previously received clearance from the FDA for a 612-patient Phase III trial in prostate cancer. The Company also conducted a Phase I/II trial with DCVax for metastatic ovarian cancer together with the University of Pennsylvania. read full: http://finance.yahoo.com/news/nw-bio-present-...00882.html
*********************************************************
Mon, 02 Jun 2014 19:05:53 GMT ~ Northwest Biotherapeutics: Academic Results Create Positive Risk/Reward
read full: http://seekingalpha.com/article/2249183-north...urce=yahoo
*********************************************************
Mon, 02 Jun 2014 15:23:00 GMT ~ If You Build It, They Will Chuckle: Northwest Bio's Super-Sized ASCO '14 Booth
read full: http://www.thestreet.com/story/12729851/1/if-..._ven=YAHOO
*********************************************************
##### chart ~ source: stockcharts.com
stockcharts.com/c-sc/sc?s=NWBO&p=D&b=5&g=0&id=p95448242713
##### chart ~ source: eoddata.com
http://chart.eoddata.com/?e=OTCBB&s=NWBO&...D&b=BB
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/NWBO/company-info
Ticker: $NWBO
OTC Market Place: Not Available
CIK code: 0001072379
Company name: Northwest Biotherapeutics, Inc.
Company website: http://www.nwbio.com
Incorporated In: DE, USA
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/NWBO/filings
Latest financials: http://www.otcmarkets.com/stock/NWBO/financials
Latest news: http://www.otcmarkets.com/stock/NWBO/news - http://finance.yahoo.com/q/h?s=NWBO+Headlines
Major holdings: http://data.cnbc.com/quotes/NWBO/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=NWBO+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/NWBO.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=NWBO
RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search
DTCC: http://search2.dtcc.com/?q=Northwest+Biothera...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...ics%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.nwbio.com
Alexa: http://www.alexa.com/siteinfo/http://www.nwbio.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.nwbio.com
Short Sales: http://www.otcmarkets.com/stock/NWBO/short-sales
Insider Disclosure: http://www.otcmarkets.com/stock/NWBO/insider-transactions
Research Reports: http://www.otcmarkets.com/stock/NWBO/research
Historical Prices: http://finance.yahoo.com/q/hp?s=NWBO+Historical+Prices
Basic Tech. Analysis: http://finance.yahoo.com/q/ta?s=NWBO+Basic+Tech.+Analysis
Company Profile: http://finance.yahoo.com/q/pr?s=NWBO+Profile
Key Statistics: http://finance.yahoo.com/q/ks?s=NWBO+Key+Statistics
Industry: http://finance.yahoo.com/q/in?s=NWBO+Industry
Insider Roster: http://finance.yahoo.com/q/ir?s=NWBO+Insider+Roster
Income Statement: http://finance.yahoo.com/q/is?s=NWBO
Balance Sheet: http://finance.yahoo.com/q/bs?s=NWBO
Cash Flow: http://finance.yahoo.com/q/cf?s=NWBO+Cash+Flow&annual
Market Watch: http://www.marketwatch.com/investing/stock/NWBO
Bloomberg: http://www.bloomberg.com/quote/NWBO:US
Morningstar: http://quotes.morningstar.com/stock/s?t=NWBO
Bussinessweek: http://investing.businessweek.com/research/st...icker=NWBO
Barchart: http://www.barchart.com/quotes/stocks/NWBO
OTC Short Report: http://otcshortreport.com/index.php?index=NWBO
Investopedia: http://www.investopedia.com/markets/stocks/NWBO/?wa=0
http://www.pennystocktweets.com/stocks/profile/NWBO
##### last known share structure ~ source: otcmarkets.com
Market Value: $337,455,320 a/o Jun 03, 2014
Shares Outstanding: 57,195,817 a/o May 14, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
##### business description ~ source: otcmarkets.com
Northwest Biotherapeutics, Inc. is a development stage biotechnology company focused on discovering, developing and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer. The Company operates in the United States and is incorporated in Delaware, USA.
DD Notes ~ http://www.ddnotesmaker.com/NWBO
(0)
(0)